Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial

Submitted ⁨⁨6⁩ ⁨months⁩ ago⁩ by ⁨realcaseyrollins@narwhal.city⁩ to ⁨Finance@narwhal.city⁩

https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html